Homozygous deletion of the CDKN2A locus, which is associated with poor prognosis in osteosarcoma, eradicates both expression of p16Ink4A and p14ARF, of which the latter is a negative regulator of MDM2 [38, 54–56]. The gene discussed is CDKN2A; the disease is osteosarcoma.